+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Oral Anti-Diabetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Oral Anti-Diabetic Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Human Recombinant Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Recombinant Insulin - Global Strategic Business Report

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Basal Insulin - Global Strategic Business Report - Product Thumbnail Image

Basal Insulin - Global Strategic Business Report

  • Report
  • August 2025
  • 179 Pages
  • Global
From
From
From
Fibroblast Growth Factors - Global Strategic Business Report - Product Thumbnail Image

Fibroblast Growth Factors - Global Strategic Business Report

  • Report
  • August 2025
  • 486 Pages
  • Global
From
Endocrinology Drugs - Global Strategic Business Report - Product Thumbnail Image

Endocrinology Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 288 Pages
  • Global
From
From
From
Insulin Injection Aids - Global Strategic Business Report - Product Thumbnail Image

Insulin Injection Aids - Global Strategic Business Report

  • Report
  • August 2025
  • 280 Pages
  • Global
From
Liraglutide and Semaglutide - Global Strategic Business Report - Product Thumbnail Image

Liraglutide and Semaglutide - Global Strategic Business Report

  • Report
  • August 2025
  • 451 Pages
  • Global
From
From
Diabetes Drugs - Global Strategic Business Report - Product Thumbnail Image

Diabetes Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Insulin Storage Devices - Global Strategic Business Report - Product Thumbnail Image

Insulin Storage Devices - Global Strategic Business Report

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Insulin Patch Pumps - Global Strategic Business Report - Product Thumbnail Image

Insulin Patch Pumps - Global Strategic Business Report

  • Report
  • August 2025
  • 285 Pages
  • Global
From
Somatostatin Analogs - Global Strategic Business Report - Product Thumbnail Image

Somatostatin Analogs - Global Strategic Business Report

  • Report
  • August 2025
  • 280 Pages
  • Global
From
Human Insulin - Global Strategic Business Report - Product Thumbnail Image

Human Insulin - Global Strategic Business Report

  • Report
  • August 2025
  • 376 Pages
  • Global
From
From
DPP-IV Inhibitors - Global Strategic Business Report - Product Thumbnail Image

DPP-IV Inhibitors - Global Strategic Business Report

  • Report
  • August 2025
  • 262 Pages
  • Global
From
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more